Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;14(16):e2500595.
doi: 10.1002/adhm.202500595. Epub 2025 May 12.

A Nanoplatform Targeting Cascade Pathways for Enhanced Triptolide Delivery in Acute Kidney Injury Therapy

Qianqian Guo  1   2   3 , Xin Lu  1   2   3 , Yanqi Zhang  4 , Zhimin Huang  5 , Shaobo Liu  1   2   3 , Li Qiao  6 , Xingjie Wu  1   2   3 , Honglei Guo  5 , Xiangchun Shen  1   2 , Huijuan Mao  5
Affiliations

A Nanoplatform Targeting Cascade Pathways for Enhanced Triptolide Delivery in Acute Kidney Injury Therapy

Qianqian Guo et al. Adv Healthc Mater. 2025 Jun.

Abstract

Triptolide (TP), the main active compound in Tripterygium wilfordii Hook F, has anti-inflammatory and antioxidant properties, making it a potential treatment option for acute kidney injury (AKI). However, the application of TP faces challenges due to its poor water solubility, low renal accumulation, and potential tissue toxicity. To overcome these limitations, TL-N@TP is engineered as a cascade-targeted nanotherapeutic system integrating triphenylphosphonium (TPP)- and lysozyme (LZM)-functionalized PEG-PLGA copolymers for renal-specific TP delivery. The effectiveness of TL-N@TP is highlighted through a tripartite targeting mechanism, involving glomerular filtration, renal tubule specificity, and mitochondrial localization. The nanoplatform is able to target damaged kidneys and localize in the renal tubular cells in AKI mice induced by lipopolysaccharide. Upon uptake by injury HK-2 cells, the nanoplatform showed antioxidant, anti-inflammatory, and antiapoptotic effects. The nanoplatform in AKI mice effectively improved renal function by facilitating the restoration of mitochondrial structure and function, concomitant with reducing oxidative stress and inflammation. These findings establish TL-N@TP as a promising nanotherapeutic strategy for AKI management.

Keywords: acute kidney injury; cascade targeting; drug delivery; glomerular filtration.

PubMed Disclaimer

References

    1. a) X. Xie, Y. Zhang, X. Su, J. Wang, X. Yao, D. Lv, Q. Zhou, J. Mao, J. Chen, F. Han, Y. Li, W. Lin, Nano Res. 2022, 15, 6315;
    1. b) Q. Chen, Y. Nan, Y. Yang, Z. Xiao, M. Liu, J. Huang, Y. Xiang, X. Long, T. Zhao, X. Wang, Q. Huang, K. Ai, Bioactive Mater. 2023, 22, 141.
    1. a) Z. Liu, X. Liu, Q. Yang, L. Yu, Y. Chang, M. Qu, Acta Biomater. 2020, 104, 158;
    1. b) E. L. Vallorz, J. Janda, H. M. Mansour, R. G. Schnellmann, Kidney Int. 2022, 102, 1073;
    1. c) Y. Hou, Y. Xin, S. Liu, Y. Li, X. Meng, J. Wang, Z. Xu, T. Sun, Y.‐G. Yang, Am. J. Transplant. 2022, 22, 2246;

MeSH terms

LinkOut - more resources